Xingmin G. Han
No. 1 Jianshe East Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
MAPK pathway inhibitors enhance radioiodine sensitivity in anaplastic thyroid carcinoma through promoting NIS expression and ARF4-mediated NIS membrane transport.
Journal: Scientific reports
Published: January 02, 2026
Lithium carbonate bridging and outcomes of radioiodine therapy in severe Graves' disease: a retrospective cohort study.
Journal: Frontiers in endocrinology
Published: December 18, 2025
Lithium carbonate pretreatment normalizes rapid iodine turnover in Graves' disease patients with an advanced radioiodine peak: a retrospective cohort study.
Journal: Journal of endocrinological investigation
Published: December 12, 2025
Noninvasive Evaluation of Trop2 Expression Using 64Cu-NOTA-Trodelvy-F(ab')2 in Gastric and Pancreatic Cancer.
Journal: Molecular pharmaceutics
Published: November 07, 2025
18F-PSMA-1007 versus 18F-FDG PET/CT in the detection of hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: September 23, 2025
Noninvasive ImmunoPET imaging of PD-L1 expression in non-small cell lung cancer and bladder cancer using [89Zr]Zr-DFO-Durvalumab.
Journal: Colloids and surfaces. A, Physicochemical and engineering aspects
Published: September 08, 2025
177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 07, 2025
Electrochemical Dichlorinative Cyclization of 1,n-Enynes by 4-Iodotoluene Catalysis.
Journal: Organic letters
Published: November 28, 2024
Recombinant Human Thyrotropin Plus Radioactive Iodine Among Patients With Thyroid Cancer: A Noninferiority Randomized Clinical Trial.
Journal: JAMA network open
Published: November 07, 2024
Retraction Note: Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis.
Journal: Cancer cell international
Published: August 06, 2024
FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis.
Journal: Scientific reports
Published: May 20, 2024
Retraction Note: Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis.
Journal: Cancer cell international
Published: April 23, 2024
Last Updated: 09/26/2026